HEALTHCARE3/17/2026 • LIVE

ABAbbVie Inc. (ABBV)

AbbVie Inc. (ABBV) is a healthcare company operating in drug manufacturers—general. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. Use this profile to monitor momentum shifts, volatility regime, and valuation signals in one dashboard.

PRICE
$221.79
+0.15% today
RISK
MEDIUM
Share this asset

Key Metrics

MARKET CAP
$392.16B
P/E RATIO
93.6
BETA
0.33
Less volatile
DIV YIELD
3.12%
52W HIGH
$244.81
52W LOW
$164.39
VOLATILITY
21.7%
30d annualized

Price Performance

30-DAY PRICE CHART

$232.86 → $221.79-4.75%
30 days agoToday

1-YEAR PERFORMANCE

$210.01 → $221.79+5.6%
$185$206$227MarAprMayJunJulAugSepOctNovDecJanFeb
ABBV | 52-week chartLast updated: 3/17/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRICABBVSECTOR AVGVS SECTOR
P/E Ratio93.6x22.0x 325%
Beta0.330.85Less volatile
Div Yield3.12%1.50%Above avg
30d Volatility21.7%22%Lower risk

TOP HEALTHCARE PEERS

Competitors Analysis

Compare ABBV's key metrics against its main healthcare sector competitors.

COMPANYPRICEMARKET CAPSECTOR
ABABBV(You are here)
$221.79$392.16BHealthcare
$287.06$260.56BHealthcareVIEW →
$238.35$574.40BHealthcareVIEW →
PFPFE
$27.70$157.54BHealthcareVIEW →
Click on a competitor to view their full analysis

Technical Analysis

AbbVie Inc. is currently trading at $221.79, which is 9.4% below its 52-week high. With a beta of 0.33, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL
30-DAY TRENDNEUTRAL
VOLUME2.1M(Below avg)

Frequently Asked Questions

Is ABBV a good buy right now?

AbbVie Inc. trades at 93.6x earnings. This is above market average, reflecting growth expectations. Current risk level is Medium based on 21.7% volatility.

Does ABBV pay dividends?

Yes, AbbVie Inc. offers a dividend yield of 3.12%. This translates to approximately $6.92 per share annually.

How volatile is ABBV?

With 30-day annualized volatility of 21.7% and beta of 0.33,ABBV is classified as Medium risk. The stock tends to be more stable than the market average.

Related Assets

Track ABBV Live

Add AbbVie Inc. to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINALIMPORT BROKER FILE
Last updated: 3/17/2026, 7:21:51 PM